Peter H K ENG
Annals of the Academy of Medicine, Singapore 2011;40(11):480-481
Chronic Disease ; economics ; Cost of Illness ; Diabetes Mellitus ; drug therapy ; economics ; Global Health ; economics ; Humans ; Singapore